TSX News -
Cardinal Board Provides Update on Takeover Bids
TORONTO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX / TSX: CDV) (“Cardinal” or “the Company”) refers to […]
Newcore Gold Announces Appointment of Vice President, Corporate Development and Investor Relations
VANCOUVER, British Columbia, Sept. 03, 2020 (GLOBE NEWSWIRE) — Newcore Gold Ltd. (“Newcore” or the “Company”) (TSX-V: NCAU) is pleased […]
Visteon to Present at Citi 2020 Global Technology Conference on Sept. 9
VAN BUREN TOWNSHIP, Mich., Sept. 03, 2020 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC), a leading global supplier of vehicle […]
ORYX Gaming Debuts in Denmark with SkillOnNet
TORONTO, Sept. 03, 2020 (GLOBE NEWSWIRE) — ORYX Gaming, a Bragg Gaming Group company (TSXV: BRAG, OTC:BRGGF), has taken its […]
Tyson Foods to Pilot Clinics to Promote Culture of Health
SPRINGDALE, Ark., Sept. 03, 2020 (GLOBE NEWSWIRE) — As part of efforts to boost the overall health and wellness of […]
CTO Realty Growth Board Approves Reorganization for Reit Qualification
DAYTONA BEACH, Fla., Sept. 03, 2020 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE American: CTO) (the “Company”) announced today […]
Madrigal Pharmaceuticals Exceeds Target Enrollment in Phase 3 MAESTRO NAFLD-1 Trial
CONSHOHOCKEN, Pa., Sept. 03, 2020 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today that it has already exceeded the […]
Reata Announces the Presentation of the Pivotal MOXIe Part 2 Study of Omaveloxolone in Friedreich’s Ataxia at the American Academy of Neurology
PLANO, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage […]
K92 Mining Announces Bulk Sample Preliminary Results at Judd Vein System and Commencement of Phase 1 Judd Drill Program
First significant exploration undertaken on Judd by K92, with approximately 109 metres of 5.5m x 5.5m development completed on Judd […]
InspireMD Announces the European Society of Cardiology 2020 “Best Poster Award” for Updated Data from the PARADIGM-EXTEND Study
TEL AVIV, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic […]
